Eli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of up to $250m.

INDIANAPOLIS and WEST LAFAYETTE, Ind. - Eli Lilly and Company (NYSE: LLY), a pharmaceutical giant with annual revenue exceeding $49 billion and an impressive 81.7% gross profit margin, and Purdue ...

Eli Lilly has unveiled plans to expand its long-standing partnership with Purdue University, with the drugmaker investing up ...

Eli Lilly and Purdue University ... investment of up to $250m over the next eight years by Lilly, to expedite innovation across the pharma pipeline. The Lilly-Purdue 360 Initiative focuses ...

Eli Lilly and Co. and Purdue University announced today a significant expansion of their long-standing alliance ... innovation at every stage of the pharmaceutical pipeline.

US pharma major Eli Lilly (NYSE: LLY) announced a significant expansion of its long-standing alliance with Purdue University, with Lilly's planned investment of up to $250 million in the collaboration ...

The investment over the next eight years could be the largest ever industry-academic agreement of its kind in the U.S., the ...

Eli Lilly and Company and Purdue University announced a significant expansion of their long-standing alliance, with Lilly's planned investment of up to $250 million in the collaboration over the next ...

The company’s market capitalization stands at $641.77 billion, reflecting its position as a prominent player in the pharmaceuticals ... Eli Lilly and Purdue University have expanded their ...

Eli Lilly is investing ... the Lilly and Purdue Research Alliance Center, according to the release. The long-time partners also announced the new Young Institute Pharmaceutical Manufacturing ...

INDIANAPOLIS and WEST LAFAYETTE, May 9, 2025 — Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their long-standing alliance ... at every ...